Home›Companies›Biotech & Pharma›Archean Sciences

Archean Sciences, Inc.

Develops human neuron chips for drug testing and computing.

Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About Archean Sciences

Archean Sciences is a private company based in Champaign, Illinois, incorporated in 2026 in Delaware. It has reported $385,000 raised in one offering on Form D since August 2026. Its chief executive is Austin Ellis-Mohr.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 27, 2026Aug 13, 2026$385,000target not set8$48,125Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Archean Sciences's Form D filed Aug 13, 2026.

Mattia Gazzola
Mattia Gazzola
Co-Founder and director
Austin Ellis-Mohr
Austin Ellis-Mohr
Co-Founder & CEO, director

Sources

  1. SECArchean Sciences, Inc. filing history
  2. ResearchUniversity of Illinois: Archean Sciences